as 03-28-2025 4:00pm EST
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Founded: | 2006 | Country: | United States |
Employees: | N/A | City: | San Francisco |
Market Cap: | 3.1B | IPO Year: | 2016 |
Target Price: | $120.20 | AVG Volume (30 days): | 374.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.63 | EPS Growth: | N/A |
52 Week Low/High: | $55.92 - $128.52 | Next Earning Date: | 05-01-2025 |
Revenue: | $591,839,000 | Revenue Growth: | 20.13% |
Revenue Growth (this year): | 17.46% | Revenue Growth (next year): | 16.93% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Patterson Chad | IRTC | Chief Commercial Officer | Mar 3 '25 | Sell | $108.77 | 2,756 | $299,770.12 | 58,440 | |
Wilson Daniel G. | IRTC | Chief Financial Officer | Mar 3 '25 | Sell | $108.77 | 2,341 | $254,630.57 | 45,307 | |
Murphy Patrick Michael | IRTC | CBO and CLO | Mar 3 '25 | Sell | $108.77 | 3,075 | $334,467.75 | 55,759 | |
Turakhia Minang | IRTC | EVP, CMO & CSO | Mar 3 '25 | Sell | $108.77 | 2,467 | $268,335.59 | 42,495 | |
Rosenbaum Marc W. | IRTC | Chief Accounting Officer | Mar 3 '25 | Sell | $108.77 | 314 | $34,153.78 | 11,507 | |
Blackford Quentin S. | IRTC | President and CEO | Mar 3 '25 | Sell | $108.77 | 8,145 | $885,931.65 | 208,741 | |
Shrishrimal Sumi | IRTC | EVP, Chief Risk Officer | Mar 3 '25 | Sell | $108.77 | 1,726 | $187,737.02 | 36,117 | |
Smith Mervin | IRTC | EVP Strategic Business Ops | Mar 3 '25 | Sell | $108.77 | 638 | $69,395.26 | 16,454 | |
Wilson Daniel G. | IRTC | Chief Financial Officer | Feb 25 '25 | Sell | $112.13 | 2,512 | $281,670.56 | 45,307 | |
Murphy Patrick Michael | IRTC | CBO and CLO | Feb 25 '25 | Sell | $110.53 | 16,330 | $1,791,041.30 | 55,759 |
IRTC Breaking Stock News: Dive into IRTC Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
StockStory
8 days ago
Zacks
11 days ago
StockStory
18 days ago
StockStory
23 days ago
MT Newswires
24 days ago
MT Newswires
24 days ago
MT Newswires
a month ago
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.